Department of Surgery, University of Michigan, Ann Arbor, MI.
Center for Healthcare Outcomes and Policy, University of Michigan, Ann Arbor, MI.
Ann Surg. 2023 Aug 1;278(2):274-279. doi: 10.1097/SLA.0000000000005654. Epub 2022 Aug 3.
To describe national trends in surgical technique and rates of reoperation for recurrence for patients undergoing ventral hernia repair (VHR) in the United States.
Surgical options for VHR, including minimally invasive approaches, mesh implantation, and myofascial release, have expanded considerably over the past 2 decades. Their dissemination and impact on population-level outcomes is not well characterized.
We conducted a retrospective cohort study of Medicare beneficiaries undergoing elective, inpatient umbilical, ventral, or incisional hernia repair between 2007 and 2015. Cox proportional hazards models were used to estimate the adjusted proportion of patients who remained free from reoperation for hernia recurrence up to 5 years after surgery.
One hundred fort-one thousand two hundred sixty-one patients underwent VHR during the study period. Between 2007 and 2018, the use of minimally invasive surgery increased from 2.1% to 22.2%, mesh use increased from 63.2% to 72.5%, and myofascial release increased from 1.8% to 16.3%. Overall, the 5-year incidence of reoperation for recurrence was 14.1% [95% confidence interval (CI) 14.0%-14.1%]. Over time, patients were more likely to remain free from reoperation for hernia recurrence 5 years after surgery [2007-2009 reoperation-free survival: 84.9% (95% CI 84.8%-84.9%); 2010-2012 reoperation-free survival: 85.7% (95% CI 85.6%-85.7%); 2013-2015 reoperation-free survival: 87.8% (95% CI 87.7%-87.9%)].
The surgical treatment of ventral and incisional hernias has evolved in recent decades, with more patients undergoing minimally invasive repair, receiving mesh, and undergoing myofascial release. Although our analysis does not address causality, rates of reoperation for hernia recurrence improved slightly contemporaneous with changes in surgical technique.
描述美国腹疝修补术(VHR)患者手术技术和复发再手术率的全国趋势。
VHR 的手术选择,包括微创方法、网片植入和筋膜松解,在过去 20 年中已经大大扩展。它们在人群水平结局中的传播和影响尚不清楚。
我们对 2007 年至 2015 年间接受择期、住院、脐部、腹侧或切口疝修补术的 Medicare 受益患者进行了回顾性队列研究。Cox 比例风险模型用于估计手术 5 年内无疝复发再手术的患者比例。
在研究期间,有 141261 例患者接受了 VHR。2007 年至 2018 年期间,微创手术使用率从 2.1%增加到 22.2%,网片使用率从 63.2%增加到 72.5%,筋膜松解术使用率从 1.8%增加到 16.3%。总体而言,5 年内疝复发再手术的发生率为 14.1%[95%置信区间(CI)14.0%-14.1%]。随着时间的推移,患者术后 5 年内无疝复发再手术的可能性更大[2007-2009 年无再手术生存率:84.9%(95%CI 84.8%-84.9%);2010-2012 年无再手术生存率:85.7%(95%CI 85.6%-85.7%);2013-2015 年无再手术生存率:87.8%(95%CI 87.7%-87.9%)]。
近年来,腹疝和切口疝的手术治疗方法不断发展,越来越多的患者接受微创修复、网片植入和筋膜松解。尽管我们的分析没有解决因果关系,但疝复发再手术率在手术技术改变的同时略有改善。